MetLife Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.32M | Buy |
27,939
+1,841
| +7% | +$94.6K | 0.01% | 1377 |
|
|
2026
Q1 | $1.55M | Sell |
26,098
-1,103
| -4% | -$71.6K | 0.01% | 1193 |
|
|
2025
Q4 | $1.68M | Sell |
27,201
-2,232
| -8% | -$137K | 0.01% | 1167 |
|
|
2025
Q3 | $1.84M | Hold |
29,433
| – | – | 0.01% | 1129 |
|
|
2025
Q2 | $2.35M | Buy |
29,433
+478
| +2% | +$40K | 0.01% | 928 |
|
|
2025
Q1 | $2.49M | Sell |
28,955
-998
| -3% | -$81.9K | 0.01% | 938 |
|
|
2024
Q4 | $2.34M | Buy |
29,953
+1,348
| +5% | +$105K | 0.01% | 960 |
|
|
2024
Q3 | $2.06M | Hold |
28,605
| – | – | 0.01% | 1000 |
|
|
2024
Q2 | $1.97M | Buy |
28,605
+2,897
| +11% | +$196K | 0.01% | 979 |
|
|
2024
Q1 | $1.87M | Sell |
25,708
-643
| -2% | -$43K | 0.01% | 979 |
|
|
2023
Q4 | $1.61M | Hold |
26,351
| – | – | 0.01% | 1044 |
|
|
2023
Q3 | $1.51M | Hold |
26,351
| – | – | 0.01% | 1031 |
|
|
2023
Q2 | $1.57M | Buy |
26,351
+316
| +1% | +$18.9K | 0.01% | 1032 |
|
|
2023
Q1 | $1.63M | Hold |
26,035
| – | – | 0.01% | 985 |
|
|
2022
Q4 | $1.63M | Sell |
26,035
-685
| -3% | -$39.3K | 0.01% | 986 |
|
|
2022
Q3 | $1.33M | Hold |
26,720
| – | – | 0.01% | 1056 |
|
|
2022
Q2 | $1.57M | Sell |
26,720
-712
| -3% | -$39.3K | 0.01% | 994 |
|
|
2022
Q1 | $1.45M | Buy |
27,432
+9,959
| +57% | +$575K | 0.01% | 1132 |
|
|
2021
Q4 | $1.06M | Hold |
17,473
| – | – | 0.01% | 1105 |
|
|
2021
Q3 | $980K | Sell |
17,473
-1,798
| -9% | -$98.7K | 0.01% | 1125 |
|
|
2021
Q2 | $1M | Hold |
19,271
| – | – | 0.01% | 1158 |
|
|
2021
Q1 | $849K | Sell |
19,271
-30,207
| -61% | -$1.27M | 0.01% | 1237 |
|
|
2020
Q4 | $1.73M | Sell |
49,478
-1,318
| -3% | -$46.8K | 0.02% | 902 |
|
|
2020
Q3 | $1.85M | Sell |
50,796
-1,008
| -2% | -$37.5K | 0.02% | 754 |
|
|
2020
Q2 | $1.95M | Buy |
51,804
+2,155
| +4% | +$86.2K | 0.02% | 725 |
|
|
2020
Q1 | $1.82M | Sell |
49,649
-1,963
| -4% | -$76.2K | 0.02% | 649 |
|
|
2019
Q4 | $2.09M | Sell |
51,612
-387
| -0.7% | -$14.4K | 0.02% | 791 |
|
|
2019
Q3 | $1.8M | Sell |
51,999
-1,467
| -3% | -$48.3K | 0.02% | 828 |
|
|
2019
Q2 | $1.69M | Sell |
53,466
-109,380
| -67% | -$3.25M | 0.02% | 883 |
|
|
2019
Q1 | $4.87M | Buy |
162,846
+108,591
| +200% | +$3.11M | 0.01% | 877 |
|
|
2018
Q4 | $1.68M | Sell |
54,255
-125
| -0.2% | -$4.56K | 0.02% | 828 |
|
|
2018
Q3 | $2.06M | Sell |
54,380
-4,662
| -8% | -$176K | 0.02% | 844 |
|
|
2018
Q2 | $2.27M | Buy |
59,042
+257
| +0.4% | +$8.66K | 0.03% | 749 |
|
|
2018
Q1 | $1.98M | Sell |
58,785
-459
| -0.8% | -$17.6K | 0.02% | 781 |
|
|
2017
Q4 | $2.63M | Buy |
+59,244
| New | +$2.7M | 0.03% | 706 |
|
Other funds holding PBH
AI
BIP
MetLife Investment Management's PBH Position: Q2 2026 in Review
MetLife Investment Management increased its Prestige Consumer Healthcare (PBH) stake by 7.1% in Q2 2026, buying an estimated $94.6K and bringing the position to 27,939 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1377.
MetLife Investment Management first reported a position in PBH in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.87M in Q1 2019. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- MetLife Investment Management held 27,939 shares of Prestige Consumer Healthcare worth $1.32M as of Q2 2026.
- MetLife Investment Management bought 1,841 Prestige Consumer Healthcare shares in Q2 2026, an estimated $94.6K.
- Prestige Consumer Healthcare made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1377 holding.
- MetLife Investment Management first reported a position in Prestige Consumer Healthcare in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Prestige Consumer Healthcare position peaked at $4.87M in Q1 2019.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.